Lumos Diagnostics has kicked off a key paediatric study in the US for its FebriDx rapid diagnostic test, marking a ...
It was a weaker, er, week for healthcare stocks on the ASX, but takeover bids, trials and expansion deals kept the sector’s ...
Medical Device Network on MSN
Biodesix and Bio-Rad expand collaboration for IVD assays development
Biodesix has expanded its collaboration with Bio-Rad for the development and clinical validation of in vitro diagnostic (IVD) ...
News Medical on MSN
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer ...
Investing.com -- Biodesix (NYSE:BDSX) stock rose 10% Wednesday after the diagnostics solutions company announced an expanded partnership agreement with Bio-Rad Laboratories to develop high complexity ...
During the ongoing federal government shutdown, many Medicare-related survey and certification activities for nursing homes ...
TipRanks on MSN
Lumos Diagnostics Marks Major Milestones in FY25 with Strategic Partnerships and U.S. Market Expansion
Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) just unveiled an announcement. Lumos Diagnostics has made significant strides in FY25, transitioning ...
Detailed price information for Adial Pharmaceuticals Inc (ADIL-Q) from The Globe and Mail including charting and trades.
Expands commercial readiness and diagnostic, manufacturing footprintAppoints new leadership in commercial strategy and technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback